Jefferies Group LLC reissued their buy rating on shares of LHC Group (NASDAQ:LHCG) in a report published on Friday. They currently have a $68.00 price objective on the health services provider’s stock. Jefferies Group also issued estimates for LHC Group’s Q3 2017 earnings at $0.65 EPS, Q4 2017 earnings at $0.69 EPS, FY2017 earnings at $2.50 EPS and FY2018 earnings at $2.75 EPS.

A number of other equities analysts have also weighed in on LHCG. Zacks Investment Research upgraded LHC Group from a hold rating to a buy rating and set a $59.00 price objective for the company in a research note on Wednesday, April 19th. Royal Bank Of Canada restated a buy rating and issued a $69.00 price target on shares of LHC Group in a research note on Friday, May 5th. Stephens set a $69.00 price target on LHC Group and gave the company a buy rating in a research note on Saturday, May 6th. Oppenheimer Holdings, Inc. restated an outperform rating and issued a $68.00 price target (up previously from $55.00) on shares of LHC Group in a research note on Monday, May 8th. Finally, Benchmark Co. lifted their price target on LHC Group from $63.00 to $72.00 and gave the company a buy rating in a research note on Thursday, June 8th. One investment analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and a consensus target price of $65.75.

Shares of LHC Group (NASDAQ LHCG) opened at 60.85 on Friday. The company has a market cap of $1.08 billion, a price-to-earnings ratio of 26.92 and a beta of 0.77. LHC Group has a 12-month low of $32.04 and a 12-month high of $69.35. The firm’s 50-day moving average price is $64.67 and its 200 day moving average price is $56.16.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.54 by $0.09. The business had revenue of $260.20 million during the quarter, compared to analyst estimates of $254.10 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The company’s revenue was up 15.1% on a year-over-year basis. During the same quarter last year, the business posted $0.52 EPS. On average, analysts predict that LHC Group will post $2.39 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “LHC Group’s (NASDAQ:LHCG) “Buy” Rating Reiterated at Jefferies Group LLC” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/08/07/lhc-groups-nasdaqlhcg-buy-rating-reiterated-at-jefferies-group-llc.html.

In other news, COO Donald Dwayne Stelly sold 3,181 shares of the business’s stock in a transaction that occurred on Thursday, June 8th. The stock was sold at an average price of $64.97, for a total transaction of $206,669.57. Following the transaction, the chief operating officer now directly owns 114,235 shares in the company, valued at approximately $7,421,847.95. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Coliseum Capital Management, L sold 162,524 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $62.80, for a total value of $10,206,507.20. The disclosure for this sale can be found here. Over the last quarter, insiders sold 682,839 shares of company stock worth $42,140,531. 14.80% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently modified their holdings of LHCG. Alps Advisors Inc. boosted its position in shares of LHC Group by 0.3% in the second quarter. Alps Advisors Inc. now owns 9,449 shares of the health services provider’s stock valued at $641,000 after buying an additional 24 shares in the last quarter. Eqis Capital Management Inc. boosted its position in shares of LHC Group by 0.8% in the first quarter. Eqis Capital Management Inc. now owns 6,486 shares of the health services provider’s stock valued at $350,000 after buying an additional 53 shares in the last quarter. Federated Investors Inc. PA boosted its position in shares of LHC Group by 4.2% in the second quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after buying an additional 66 shares in the last quarter. Louisiana State Employees Retirement System boosted its position in shares of LHC Group by 1.7% in the first quarter. Louisiana State Employees Retirement System now owns 6,100 shares of the health services provider’s stock valued at $329,000 after buying an additional 100 shares in the last quarter. Finally, Arizona State Retirement System boosted its position in shares of LHC Group by 1.3% in the second quarter. Arizona State Retirement System now owns 7,818 shares of the health services provider’s stock valued at $531,000 after buying an additional 100 shares in the last quarter. Institutional investors and hedge funds own 84.97% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.